Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Iowa City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Peoria, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
Status: Enrolling, Phase II
Updated: 7/2/2014
mi
from
Portland, OR
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
Status: Enrolling
Updated: 1/26/2015
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Columbia, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Danville, PA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Flint, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Greenville, SC
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Iowa City, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Jupiter, FL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Kettering, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lakeland, FL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Wichita, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Adrian, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Bismarck, ND
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Clive, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Denver, CO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Denver, CO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Dodge City, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Duluth, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Franklin, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Fridley, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Great Falls, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Kansas City, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Kokomo, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
La Porte, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lansing, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lawrence, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lima, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lincoln, NE
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Marietta, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Marshfield, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Martinez, CA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Minocqua, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Missoula, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Monmouth, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Mountain View, CA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Oakland, CA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Omaha, NE
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Oregon, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Pekin, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Peoria, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Rolla, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
South Bend, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Tiffin, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Urbana, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Waconia, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Wauseon, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Wichita, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Woodbury, MN
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
mi
from
Charlotte, NC
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
mi
from
Chicago, IL
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
mi
from
Danville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Status: Enrolling, Phase I
Updated: 11/27/2013
mi
from
Bethesda, MD
Click here to add this to my saved trials
Acromegaly Clinical Trial
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Status: Enrolling
Updated: 6/29/2015
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Melanoma Clinical Trial
Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
Status: Enrolling, Phase I
Updated: 2/2/2010
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 9/19/2012
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 9/19/2012
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Status: Enrolling
Updated: 3/26/2015
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Allentown, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Bismarck, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Burlingame, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Cedar City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Cooperstown, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Morristown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Ottawa, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Pawtucket, RI
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Pekin, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Provo, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Shawnee Mission, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Sioux City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Titusville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Wichita, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Wichita, KS
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease
Status: Enrolling
Updated: 12/1/2012
mi
from
Bethesda, MD
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 66